生物標記在發炎性腸道疾病之應用

蔡易展 ； 林春吉

《臨床醫學月刊》 82卷3期 (2018/09) Pp. 554-557

https://doi.org/10.6666/ClinMed.201809_82(3).0101

摘要

發炎性腸道疾病是腸胃系統的慢性發炎疾患。因為來發炎性腸道疾病需要更精準、非侵入及客觀的評估發炎狀況，生物標記在近期有非常多的發展。本文就診斷、評估疾病嚴重度、治療效果、評估復發的各個面向來介紹目前臨床上用來評估腸道發炎狀態的各種生物標記。

關鍵字

發炎性腸道疾病 ； 潰瘍性大腸炎 ； 克隆氏症 ； 生物標記

參考文獻

Molodecky NA, Soon IS, Rabi DM, et al, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.

Sands BE: Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology 2015;149:1275-85.

Menees SB, Powell C, Kurlander J, et al, A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol 2015;110:444-54.

van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.

Kaiser T, Langhorst J, Wittkowski H, et al, Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007;56:1706-13.